For: | Rodpothong P, Auewarakul P. Viral evolution and transmission effectiveness. World J Virol 2012; 1(5): 131-134 [PMID: 24175217 DOI: 10.5501/wjv.v1.i5.131] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v1/i5/131.htm |
Number | Citing Articles |
1 |
Firzan Nainu, Rufika Shari Abidin, Muh. Akbar Bahar, Andri Frediansyah, Talha Bin Emran, Ali A Rabaan, Kuldeep Dhama, Harapan Harapan. SARS-CoV-2 reinfection and implications for vaccine development. Human Vaccines & Immunotherapeutics 2020; 16(12): 3061 doi: 10.1080/21645515.2020.1830683
|
2 |
Luis Alvarez, Miguel Colom, Jean-David Morel, Jean-Michel Morel. Computing the daily reproduction number of COVID-19 by inverting the renewal equation using a variational technique. Proceedings of the National Academy of Sciences 2021; 118(50) doi: 10.1073/pnas.2105112118
|
3 |
Jean-David Morel, Jean-Michel Morel, Luis Alvarez, Benjamin Althouse. Time warping between main epidemic time series in epidemiological surveillance. PLOS Computational Biology 2023; 19(12): e1011757 doi: 10.1371/journal.pcbi.1011757
|
4 |
Angela Andreella, Antonietta Mira, Spyros Balafas, Ernst-Jan C. Wit, Fabrizio Ruggeri, Giovanni Nattino, Giulia Ghilardi, Guido Bertolini. A predictive model for planning emergency events rescue during COVID-19 in Lombardy, Italy. Statistical Methods & Applications 2024; 33(2): 635 doi: 10.1007/s10260-023-00725-x
|
5 |
Reinhard Schlickeiser, Martin Kröger. Reasonable Limiting of 7-Day Incidence per Hundred Thousand and Herd Immunization in Germany and Other Countries. COVID 2021; 1(1): 130 doi: 10.3390/covid1010012
|
6 |
A. I. Blokh, N. A. Pen’evskaya, N. V. Rudakov, I. I. Lazarev, O. A. Mikhailova, A. S. Fedorov, Y. A. Pnevsky. Epidemic Potential of COVID-19 in Omsk Region during Anti-Epidemic Measures. Problems of Particularly Dangerous Infections 2020; (3): 36 doi: 10.21055/0370-1069-2020-3-36-42
|
7 |
Krystal J. Godri Pollitt, Jordan Peccia, Albert I. Ko, Naftali Kaminski, Charles S. Dela Cruz, Daniel W. Nebert, Juergen K.V. Reichardt, David C. Thompson, Vasilis Vasiliou. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Human Genomics 2020; 14(1) doi: 10.1186/s40246-020-00267-3
|
8 |
Bikash Chandra Singh, Zulfikar Alom, Haibo Hu, Mohammad Muntasir Rahman, Mrinal Kanti Baowaly, Zeyar Aung, Mohammad Abdul Azim, Mohammad Ali Moni. COVID-19 Pandemic Outbreak in the Subcontinent: A Data Driven Analysis. Journal of Personalized Medicine 2021; 11(9): 889 doi: 10.3390/jpm11090889
|
9 |
Shalini Upadhyay. Viral Infections and Antiviral Therapies. 2023; : 39 doi: 10.1016/B978-0-323-91814-5.00014-3
|
10 |
Barsha Dassarma, Satyajit Tripathy, Matimbha Chabalala, Motlalepula Gilbert Matsabisa. Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations. Aging and disease 2022; 13(1): 29 doi: 10.14336/AD.2021.0611
|
11 |
J.R. Nelson, A. Lu, J.P. Maestre, E.J. Palmer, D. Jarma, K.A. Kinney, T.H. Grubesic, M.J. Kirisits. Space-time analysis of COVID-19 cases and SARS-CoV-2 wastewater loading: A geodemographic perspective. Spatial and Spatio-temporal Epidemiology 2022; 42: 100521 doi: 10.1016/j.sste.2022.100521
|
12 |
Amanda J. Gibson, David J. Paton, Dirk Werling. Veterinary Vaccines. 2021; : 37 doi: 10.1002/9781119506287.ch4
|
13 |
Sung J. Yoo, Taeyong Kwon, Young S. Lyoo. Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure. Clinical and Experimental Vaccine Research 2018; 7(1): 1 doi: 10.7774/cevr.2018.7.1.1
|
14 |
Tchavdar T. Marinov, Rossitza S. Marinova. Dynamics of COVID-19 using inverse problem for coefficient identification in SIR epidemic models. Chaos, Solitons & Fractals: X 2020; 5: 100041 doi: 10.1016/j.csfx.2020.100041
|
15 |
Frank E. Marino, Nicole T. Vargas, Melissa Skein, Tegan Hartmann. Metabolic and inflammatory health in SARS-CoV-2 and the potential role for habitual exercise in reducing disease severity. Inflammation Research 2022; 71(1): 27 doi: 10.1007/s00011-021-01517-3
|
16 |
Richard A. Kaslow, David M. Bell. Viral Infections of Humans. 2022; : 1 doi: 10.1007/978-1-4939-9544-8_1-1
|
17 |
N. G. Ganyukova, M. I. Likstanov, M. V. Kosinova, I. N. Kushnir, V. G. Moses, K. B. Moses. Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia. Fundamental and Clinical Medicine 2020; 5(4): 8 doi: 10.23946/2500-0764-2020-5-4-8-13
|
18 |
Rhiane Moody, Kirsty L. Wilson, Jennifer C. Boer, Jessica K. Holien, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski. Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity. Frontiers in Bioinformatics 2021; 1 doi: 10.3389/fbinf.2021.709533
|
19 |
Richard A. Kaslow, David M. Bell. Viral Infections of Humans. 2023; : 1 doi: 10.1007/978-1-4939-9544-8_1-2
|
20 |
Davide Mohammad Reza Beigi, Greta Pellegrino, Marius Cadar, Ilaria Bisconti, Francesca Romana Di Ciommo, Katia Stefanantoni, Fabrizio Conti, Valeria Riccieri. Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication. Open Access Rheumatology: Research and Reviews 2022; : 133 doi: 10.2147/OARRR.S367424
|
21 |
François Louchet. A Brief Theory of Epidemic Kinetics. Biology 2020; 9(6): 134 doi: 10.3390/biology9060134
|
22 |
Michèle Bergmann, Monika Freisl, Katrin Hartmann. Prophylaxe der kaninen Parvovirose. Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 2021; 49(01): 44 doi: 10.1055/a-1319-4564
|
23 |
A. I. Blokh, N. A. Penievskaya, N. V. Rudakov, I. I. Lazarev. Epidemic potential of COVID-19 in Omsk region and assessment of the anti-epidemic measures. Fundamental and Clinical Medicine 2020; 5(3): 8 doi: 10.23946/2500-0764-2020-5-3-8-17
|
24 |
Fok-Moon Lum, David Lee, Tze-Kwang Chua, Jeslin J. L. Tan, Cheryl Y. P. Lee, Xuan Liu, Yongxiang Fang, Bernett Lee, Wearn-Xin Yee, Natasha Y. Rickett, Po-Ying Chia, Vanessa Lim, Yee-Sin Leo, David A. Matthews, Julian A. Hiscox, Lisa F. P. Ng, Ana Fernandez-Sesma, Anita K. McElroy, Mark T. Heise. Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity. mSphere 2018; 3(2) doi: 10.1128/mSphereDirect.00120-18
|
25 |
Sagar Dholariya, Deepak Narayan Parchwani, Ragini Singh, Amit Sonagra, Anita Motiani, Digishaben Patel. Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance. Indian Journal of Clinical Biochemistry 2021; 36(4): 451 doi: 10.1007/s12291-021-00991-0
|